Andrey Semechkin - 25 Apr 2022 Form 4 Insider Report for International Stem Cell CORP (ISCO)

Role
Chief Executive Officer, Director, 10%+ Owner
Signature
/s/ Russell Kern, Attorney-in-Fact
Issuer symbol
ISCO
Transactions as of
25 Apr 2022
Net transactions value
$0
Form type
4
Filing time
26 Apr 2022, 18:39:14 UTC
Previous filing
11 Jun 2021
Next filing
08 Nov 2023
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ISCO Stock Option (Right to Buy) Award $0 +1,000,000 $0.000000 1,000,000 25 Apr 2022 Common Stock 1,000,000 $0.4450 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 3/36th of the shares underlying such options shall vest on 07/25/2022, and the remaining share in equal monthly installments over a period of 33 months.

Remarks:

See EX-24, Power of Attorney